ETF Holdings Breakdown of DNA

Stock NameGinkgo Bioworks Holdings
TickerDNA(USD) NYSE
TYPECommon Stock
CountryUSA
ISINUS37611X1000

News associated with DNA

Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Shares Purchased by Exchange Traded Concepts LLC
Exchange Traded Concepts LLC lifted its holdings in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA – Free Report) by 63.0% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 311,846 shares of the company’s stock after purchasing an additional 120,572 shares during the quarter. Exchange […] - 2025-06-18 08:18:50
Squarepoint Ops LLC Sells 60,696 Shares of Ginkgo Bioworks Holdings, Inc. (NYSE:DNA)
Squarepoint Ops LLC reduced its holdings in shares of Ginkgo Bioworks Holdings, Inc. (NYSE:DNA – Free Report) by 58.8% in the 4th quarter, Holdings Channel.com reports. The fund owned 42,490 shares of the company’s stock after selling 60,696 shares during the period. Squarepoint Ops LLC’s holdings in Ginkgo Bioworks were worth $417,000 as of its […] - 2025-06-06 08:14:56
Millennium Management LLC Buys 523,571 Shares of Ginkgo Bioworks Holdings, Inc. (NYSE:DNA)
Millennium Management LLC increased its stake in shares of Ginkgo Bioworks Holdings, Inc. (NYSE:DNA – Free Report) by 357.4% during the 4th quarter, Holdings Channel.com reports. The firm owned 670,065 shares of the company’s stock after acquiring an additional 523,571 shares during the quarter. Millennium Management LLC’s holdings in Ginkgo Bioworks were worth $6,580,000 at […] - 2025-05-28 07:56:51
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Shares Acquired by Bank of America Corp DE
Bank of America Corp DE grew its position in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA – Free Report) by 780.6% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 3,764,455 shares of the company’s stock after acquiring an additional 3,336,964 shares during the period. Bank of […] - 2025-05-16 09:03:08
BNP Paribas Financial Markets Increases Stake in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA)
BNP Paribas Financial Markets raised its holdings in shares of Ginkgo Bioworks Holdings, Inc. (NYSE:DNA – Free Report) by 80.6% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 285,111 shares of the company’s stock after buying an additional 127,249 shares during […] - 2025-05-16 08:24:57
Tower Research Capital LLC TRC Has $167,000 Stake in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA)
Tower Research Capital LLC TRC lessened its holdings in shares of Ginkgo Bioworks Holdings, Inc. (NYSE:DNA – Free Report) by 18.7% during the fourth quarter, HoldingsChannel.com reports. The firm owned 16,972 shares of the company’s stock after selling 3,899 shares during the quarter. Tower Research Capital LLC TRC’s holdings in Ginkgo Bioworks were worth $167,000 […] - 2025-05-07 08:32:53
Ginkgo Bioworks (NYSE:DNA) versus Palisade Bio (NASDAQ:PALI) Financial Contrast
Ginkgo Bioworks (NYSE:DNA – Get Free Report) and Palisade Bio (NASDAQ:PALI – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, profitability, valuation, analyst recommendations, risk, institutional ownership and dividends. Analyst Ratings This is a breakdown of […] - 2025-05-07 06:08:50
Marshall Wace LLP Makes New $665,000 Investment in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA)
Marshall Wace LLP purchased a new stake in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA – Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 67,684 shares of the company’s stock, valued at approximately $665,000. Marshall Wace LLP owned approximately 0.12% of Ginkgo […] - 2025-05-02 08:32:47
SBI Securities Co. Ltd. Purchases Shares of 2,905 Ginkgo Bioworks Holdings, Inc. (NYSE:DNA)
SBI Securities Co. Ltd. purchased a new stake in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA – Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 2,905 shares of the company’s stock, valued at approximately $29,000. Other institutional investors have also […] - 2025-03-13 08:02:49

DNA institutional holdings

The following institutional investment holdings of DNA have been identified

Date ETF ISIN/Name Num Shares Book value
2025-06-26 IE00BF4RFH31 (iShares MSCI World Small Cap UCITS ETF USD (Acc)) 17,082USD 164,158
2025-04-02 IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc) 12,649USD 75,388 5.0%
2025-06-26 IE000T9EOCL3 (iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc)) 416USD 3,998
Total =30,147 USD 243,544
Book value of shares is calculated on the adjusted close price of each day (row).

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.